#ASCO2017 (Unpublished results) – Risk-Based Approach to Chemotherapy Duration Recommended for Stage III Colon Cancer – ASCO Daily News(free) AND ASCO2017:The IDEA Collaboration: Global Study Sets New Risk-Based Standard to Personalize Chemotherapy for Colon Cancer After Surgery – ASCO Post (free)
Commentaries: Chemo Cut in Half Following Surgery Without Increased Recurrence Risk in Patients With Low-Risk Colon Cancer – Targeted Oncology (free) Less Is More: Patients With Colon Cancer Get a Chemo Break – Medscape (free registration required) Cutting Chemo Time in Low-Risk Colon Ca an Option – MedPage Today (free registration required)
#ASCO2017 – CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial – The Lancet Oncology (link to abstract – $ for full-text)
#ASCO2017 – Small studies get big headlines at ASCO 2017 – HealthNewsReview (free)
#ASCO2017 – Survival in a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Cancer Treatment5 Jun, 2017 | 14:52h | UTC
Commentaries: Quickly reporting cancer complications may boost survival – STAT News (free) AND If This Were a Drug, the Price Would Be $100,000 – Medscape (free registration required) AND How a simple tech tool can help cancer patients live longer – The Washington Post (free)
“For surveillance of cancer, digital tracking of patient-generated data improves survival”. “The cost of digital tracking is very low and > 5 months median survival improvement is more than cancer drugs that cost > $100,000” (RT @EricTopol see Tweets and Answers)
#ASCO2017 – Abiraterone for Prostate Cancer
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer – New England Journal of Medicine (free) AND Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy – New England Journal of Medicine (free)
Association of a Bundled-Payment Program With Cost and Outcomes in Full-Cycle Breast Cancer Care – JAMA Oncology (link to abstract – $ for full-text)
Commentary: ‘Bundled’ Payments Beat Fee-for-Service: Cost, quality of care, and survival rates all better – MedPage Today (free registration required)
Related: Value-Based Care in the Worldwide Battle Against Cancer – Cureus (free)
Cancer drugs are getting better and dearer – The Economist (a few articles per month are free) (RT @pash22 see Tweet)
See more articles and commentaries about “financial toxicity” of cancer treatments in our April 27 issue, see #8.
Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk30 May, 2017 | 15:27h | UTC
Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of seven prospective cohorts in Europe – British Journal of Cancer (free)
Commentaries: Why your waist measurement can predict cancer risk – The Guardian (free) AND Large Waist Raises Cancer Risk – Medscape (free registration required)
Exercise and other non-pharmaceutical interventions for cancer-related fatigue in patients during or after cancer treatment29 May, 2017 | 15:21h | UTC
Exercise and other non-pharmaceutical interventions for cancer-related fatigue in patients during or after cancer treatment: a systematic review incorporating an indirect-comparisons meta-analysis – British Journal of Sports Medicine (free)
Clinical relevance of thrombocytosis in primary care: a prospective cohort study of cancer incidence using English electronic medical records and cancer registry data – British Journal of General Practice (link to abstract – $ for full-text)
Commentaries: Cautions and caveats help buoy Guardian story on using high platelet count for cancer detection – HealthNewsReview (free) High blood platelet count ‘as good a cancer predictor as a lump in the breast’ – The Guardian (free)
Thrombocytosis seems to be a risk marker of cancer in adults, but questions remain about the clinical usefulness of these findings.
American Society of Clinical Oncology (ASCO) 2017 Annual Meeting
Can cashews keep colon cancer patients alive? Study says yes — but cautions abound – STAT News (free) AND Reducing Risk After Cancer: Healthy Lifestyle (and Tree Nuts) – Medscape (free registration required)
Diet, Nutrition, Physical Activity and Breast Cancer – American Institute for Cancer Research (free PDF)
Commentaries: Today’s alcohol and breast cancer headlines are wrong: Here’s how news reports could have done better – HealthNewsReview(free) AND ‘Half a glass of wine every day’ increases breast cancer risk – BBC Health News (free) AND Just One Drink a Day Raises Breast Cancer Risk – Medscape (free registration required)
Editorial 1: The USPSTF Recommendation on Thyroid Cancer Screening: Don’t “Check Your Neck” (free)
Editorial 2: Cancer Screening, Overdiagnosis, and Regulatory Capture (free)
Editorial 3: How to Look for Thyroid Cancer (free)
Commentaries: No Symptoms, No Thyroid Screening, Says USPSTF – Medscape (free registration required) AND Don’t Screen For Thyroid Cancer, Task Force Says – NPR Health News (free) AND USPSTF Says No to Thyroid Cancer Screening – MedPage Today (free registration required)
The USPSTF recommended against screening for thyroid cancer in asymptomatic adults with “grade D” recommendation (Grade D = “The USPSTF recommends against the service. There is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits”).
Incidental pulmonary nodules discovered outside the context of screening or cancer follow-up are increasingly common in clinical practice. The purpose of these updated recommendations is to reduce the number of unnecessary follow-up examinations while providing practical guidance on follow-up intervals for selected larger nodules.
Source: ASCO Issues Guideline on Castrate-Resistant Prostate Cancer – Medscape (free registration required)